about
Ether lipid biosynthesis: isolation and molecular characterization of human dihydroxyacetonephosphate acyltransferasecDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolasePlatelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseThe novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shockRelationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy.Role of cytokines and their inhibitors in acute pancreatitisFluid shear stress increases neutrophil activation via platelet-activating factor.Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthmaInfection and inflammation-induced proatherogenic changes of lipoproteins.Bacterial clearance is improved in septic mice by platelet-activating factor-acetylhydrolase (PAF-AH) administration.Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient miceLipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways.Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonistNo evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis.Optimizing the diagnosis of food allergy.Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.Platelet activating factor: A potential biomarker in acute coronary syndrome?Platelet-activating Factor Mediates Endotoxin Tolerance by Regulating Indoleamine 2,3-Dioxygenase-dependent Expression of the Suppressor of Cytokine Signaling 3.Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages.Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease.Agonist-independent desensitization and internalization of the human platelet-activating factor receptor by coumermycin-gyrase B-induced dimerization.Potential new therapies for the treatment of acute pancreatitis.Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.Enhancement of endothelial permeability by coculture with peripheral blood mononuclear cells in the presence of HLA Class II antibody that was associated with transfusion-related acute lung injury.Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium.
P2860
Q24336292-48AD8CD7-1B92-4995-96BD-159E73E7BDF2Q24336429-8DB192DA-A15E-464B-A15B-F83DB4DF65C5Q24562119-8F73DB5C-E361-403D-AF2C-EF0BF64639CEQ33490130-00707432-432F-4BD6-9510-BB73A9818E60Q33575941-BD1EBD4C-DD58-49C0-AE49-458C38A6E47CQ33617636-BFDE320F-8D93-480F-AB27-DA853AE6AA46Q33736487-FACD24C4-7DF7-4978-82C6-6B97F128FF00Q33848692-1A85B638-4B8F-40C0-8166-0A6CFA0636A7Q33935040-815442A5-A05A-4B96-A36F-48F43B5CF06AQ34999226-EE134724-F8EA-4777-86D4-213E0A72083EQ35088319-289408EF-0D0B-496E-B68C-337C029F741BQ35099704-6E3EB949-7D0D-4B8D-8B20-30B162E4B573Q35581372-B64F5DA5-FFBA-40DF-9F42-F2ED76439E40Q35609288-F2DAEF81-23AE-47D8-8969-C9386A0F2C49Q36279540-734A0F3F-B1FC-4171-BA63-B80F72FBA8C5Q36400935-C8578FE7-A0F7-4A04-BB2C-EC1D8430B4AAQ38993442-2F38A31E-16A9-46FC-8455-A4C0F73D84E6Q40376015-37AD2493-83E8-481B-8E44-8BA4363355E0Q40400107-B5518D7D-DF90-4C9D-AF63-E3C99F020D1FQ42425245-A9315B10-841F-4275-959B-936591D28E8CQ43735996-83EDA3C8-35D4-416F-B0CB-36401DBA5DE1Q44447205-51692FCE-58A7-42EF-8520-3E7B91494A76Q47614767-1B2E3F34-95AE-4BDA-945C-D33E1062C0BEQ47712226-0D7AF15B-35FD-4E0D-83CD-C2F06247A476Q50556977-F65F5996-488A-4571-9EE1-EECEE6E0A744Q52608788-689A585E-5857-4FE3-88D9-413455941074
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Platelet-activating factor: a mediator for clinicians.
@en
type
label
Platelet-activating factor: a mediator for clinicians.
@en
prefLabel
Platelet-activating factor: a mediator for clinicians.
@en
P2093
P1476
Platelet-activating factor: a mediator for clinicians.
@en
P2093
Imaizumi TA
McIntyre TM
Prescott SM
Stafforini DM
Zimmerman GA
P356
10.1111/J.1365-2796.1995.TB00894.X
P407
P577
1995-07-01T00:00:00Z